myCROBE™ STI Application
Sexually Transmitted Infections
LaunchedActive
Key Facts
About GeneProof
GeneProof is a Brno-based molecular diagnostics company with a comprehensive portfolio focused on infectious diseases (bloodborne, respiratory, STIs, neuroinfections) and genetic conditions like thrombotic mutations. Its core offerings include PCR test kits, extraction reagents, and the myCROBE™ fully automated system, all designed for clinical laboratory use. The 2022 merger with ALPCO significantly expanded its global commercial reach and operational scale, positioning it as a competitive player in the IVD market with a strong emphasis on regulatory compliance (IVDR). The company targets healthcare professionals through a worldwide distributor network.
View full company profileTherapeutic Areas
Other Sexually Transmitted Infections Drugs
| Drug | Company | Phase |
|---|---|---|
| STI Diagnostic Panel | DK Diagnostics | Development |
| Sexual Health Diagnostics | Quarksen | Pre-clinical |
| STI Multiplex PCR Panels | Biomiga | Commercial |
| VELO STI Test(s) | LEX Diagnostics | Development |